PRESS RELEASE published on 11/12/2025 at 07:30, 6 months 21 days ago Inside Information / Other news releases Adocia files patent for AdoXLongTM platform to extend duration of action for peptides in diabetes and obesity treatment. BioChaperone® platform updated with feasibility studies Obesity Treatment Diabetes Treatment Patent Filing ADOCIA AdoXLongTM
BRIEF published on 10/21/2025 at 10:47, 7 months 12 days ago Crossing thresholds at ADOCIA Warrants Actions Crossing Thresholds ADOCIA Vester Finance
BRIEF published on 10/15/2025 at 08:50, 7 months 19 days ago Positive results for BioChaperone® Lispro insulin in Phase 3 Clinical Trial Type 1 Diabetes ADOCIA BioChaperone® Tonghua Dongbao
PRESS RELEASE published on 10/15/2025 at 08:45, 7 months 19 days ago Inside Information / Other news releases ADOCIA and Tonghua Dongbao announce positive Phase 3 results for Ultra-Rapid Insulin BioChaperone Lispro in Type 1 Diabetes treatment, showing non-inferior HbA1c reduction and improved blood glucose control post-meal Type 1 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 07/25/2025 at 08:50, 10 months 9 days ago Adocia and Tonghua Dongbao Report Phase 3 Success for Ultra-Rapid Insulin Diabetes Treatment Clinical Trial Phase 3 Results ADOCIA BioChaperone® Lispro
PRESS RELEASE published on 07/25/2025 at 08:45, 10 months 9 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 1 year 1 month ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
BRIEF published on 02/28/2025 at 19:33, 1 year 3 months ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 3 months ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 1 year 3 months ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
Published on 06/03/2026 at 09:01, 39 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 4 hours 42 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 9 hours 40 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 11 hours 10 minutes ago INEO Announces Effective Date of Share Consolidation
Published on 06/03/2026 at 09:30, 9 minutes ago LION E-Mobility AG: Ian Mukherjee to assume Role of Chairman of the Board of Directors
Published on 06/03/2026 at 09:30, 10 minutes ago Skyborn Renewables appoints Michael Klingele as Chief Operating Officer
Published on 06/03/2026 at 09:27, 12 minutes ago Bajaj Mobility AG for its 100% subsidiary KTM AG: Senior Executive to strengthen R&D - Christof Lischka appointed Chief Technology and Product Officer of KTM AG
Published on 06/03/2026 at 09:18, 22 minutes ago Homann Holzwerkstoffe publishes its 2025 Sustainability Statement and is already using the revised ESRS
Published on 06/03/2026 at 09:05, 35 minutes ago Dstny Launches Always-On Communications: Business Communications That Never Sleep
Published on 06/03/2026 at 08:45, 55 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 15 hours 36 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 15 hours 58 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 16 hours ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 1 hour ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
